|
Oral Cephalosporins |
Products |
Pharmacopoeia |
First Generation |
| Cefalexin |
EP/BP/USP/CP/JP |
| Cefradine |
EP/BP/USP |
| Cefadroxil |
EP/BP/USP |
Second Generation
|
| Cefuroxime Axetil Amorphous |
EP/BP/USP |
| Cefuroxime Axetil Crystalline |
USP |
| Cefprozil |
USP |
Third Generation
|
| Cefixime |
EP/BP/USP |
| Cefpodoxime Proxetil |
JP/USP |
| Cefdinir |
JP |
| Ceftibuten |
In-House |
| Cefditoren Pivoxil |
JP |
|
 |
Sterile Cephalosporins |
First Generation
|
| Cefazolin Sodium |
EP/BP/USP |
| Cephalothin Sodium |
EP/BP/USP/CP |
Second Generation
|
| Cefuroxime Sodium |
EP/BP/USP |
| Cefoxitin Sodium |
EP/BP/USP |
| Cefotetan Sodium |
USP |
| Cefonicid Sodium |
USP |
| Cefamandole Nafate |
USP/EP |
Third Generation
|
| Cefotaxime Sodium |
EP/BP/USP |
| Ceftriaxone Sodium |
EP/BP/USP |
| Cefoperazone Sodium |
EP/CP |
| Ceftazidime |
EP/BP/USP |
| Ceftizoxime Sodium |
USP |
Fourth Generation
|
| Cefepime HCl |
USP |
| Cefpirome Sulphate |
In-House |
|
|
Sterile Veterinary Cephalosporins |
|
First Generation |
| Cefalonium |
BP |
Second Generation |
| Ceftiofur Sodium |
In-House |
| Cefquinome |
In-House |
|
|
Non Cephalosporins - Betalactams |
| Piperacillin |
EP/USP/JP |
| Tazobactam |
In-House |
| Tazobactam + Piperacillin (1:8) |
USP |
| Meropenem |
USP |
|
|
|
Speciality Nutraceutical/Food/Dietary Ingredients
|
| SAMe (S-Adenosyl Methionine) |
USP |
| Resveratrol |
In-House |
| Biotin (Vitamin H) |
EP/USP/JP |
| Co-Enzyme Q10 |
In-House |
|
|
BP - British Pharmacopoeia CP - Chinese Pharmacopoeia EP - European Pharmacopoeia JP - Japanese Pharmacopoeia USP - United States Pharmacopoeia |
|
Product exploitation, including development, sales and offer for sale are performed where permissible by patent law. This presentation is not and should not constitute as an offer for sale in territories where it is not permitted by law. |
|
